Evista
Product Images NDC 54868-4170

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Evista (NDC 54868-4170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label (EVISTA 60 mg package label)

Evista 60 mg tablet bottle label from Physicians Total Care, Inc. The label indicates 60 tablets of raloxifene HCl. It includes warnings about federal law prohibiting dispensing without a prescription and storage instructions to keep the medication at controlled room temperature, away from children and heat.*

FDA Label Image

Chemical Structure (Evista F001 V1)

Chemical structure of the active ingredient in Evista, showing molecular bonds including phenyl rings, a thiophene ring with hydroxyl groups, and a piperidine moiety with a chloride ion.*

FDA Label Image

Figure 1 (Evista F002 V1)

Two line graphs showing total hip mean percentage change from baseline over 24 months after randomization. The first graph compares EVISTA and placebo subjects, while the second graph compares CE (conjugated estrogens 0.625 mg/day), EVISTA, and placebo subjects. The y-axis represents percentage change, and the x-axis represents months after randomization.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.